Vision-Sciences Inc.
Uroplasty, Vision-Sciences merge as Cogentix
MDT buys hearing aid maker Sophono | The week in medtech M&A
Uroplasty, Vision-Sciences shareholders OK merger
CAH top suitor for JNJ’s Cordis unit | The week in medtech M&A
Uroplasty, Vision-Sciences set date for merger vote
Uroplasty and Vision-Sciences shareholders will vote on the proposed all-stock merger deal between the two companies on March 30, according to a regulatory filing.
Stryker bid for Smith & Nephew could be in the works | The week in medtech M&A
Volcano’s commercial sales prez bows out | Personnel Moves
Cambridge Heart chairman, ex-CEO both resign | Personnel Moves
Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company.
Afghanistan: Vision-Sciences touts EndoSheath data from field hospital
Vision-Sciences (NSDQ:VSCI) said a small study of its EndoSheath bronchoscopy device in a field hospital in Afghanistan found that the single-use device reduces the risk of cross-contamination and avoids the need for complex sterilization procedures for bronchoscopes.
